Pixium Vision announces that it has negotiated a six-month extension, to January 13, 2024, to the maturity date of 125 outstanding bonds redeemable in cash and/or new shares (ORNAN 2022), representing an amount of 1.25 million euros.

These securities, issued under the previously terminated financing agreement with ESGO, may be converted by ESGO, or will have to be repaid by Pixium Vision at their nominal value if they are not converted before their maturity date.

Pixium Vision remains actively seeking financing solutions, and is working with two investment banks mandated to support it. The bioelectronics company's cash capacity is estimated to cover the period up to the end of September 2023.

Copyright (c) 2023 CercleFinance.com. All rights reserved.